Cargando…
Arrhythmia Monitoring for Risk Stratification in Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiomyopathy, presenting significant clinical heterogeneity. Arrhythmia risk stratification and detection are critical components in the evaluation and management of all cases of HCM. The 2020 American Heart Association/American Colleg...
Autores principales: | Du, Darson, Li, Christopher O.Y., Ong, Kevin, Parsa, Ashkan, Weissler-Snir, Adaya, Geske, Jeffrey B., Laksman, Zachary |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9039556/ https://www.ncbi.nlm.nih.gov/pubmed/35495864 http://dx.doi.org/10.1016/j.cjco.2022.01.001 |
Ejemplares similares
-
International Practice Patterns in the Detection and Management of Arrhythmias in Patients With Hypertrophic Cardiomyopathy
por: Cheung, Matthew, et al.
Publicado: (2022) -
Safety of Outpatient Initiation of Disopyramide for Obstructive Hypertrophic Cardiomyopathy Patients
por: Adler, Arnon, et al.
Publicado: (2017) -
Dual myosin binding protein C3 and potassium voltage-gated channel subfamily H member 2 co-inherited pathogenic variants in a patient with hypertrophic cardiomyopathy and long QT 2 syndrome: A case report
por: Alvarez, Chikezie K., et al.
Publicado: (2021) -
Bluetooth-Enabled Implantable Cardiac Monitors and Two-Way Smartphone Communication for Patients With Hypertrophic Cardiomyopathy
por: Safabakhsh, Sina, et al.
Publicado: (2021) -
Establishment of a Dedicated Inherited Cardiomyopathy Clinic: From Challenges to Improved Patients’ Outcome
por: Smith, Emily, et al.
Publicado: (2022)